Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.
| Autor: | Fowler, Daniel H.1 dhfowler@helix.nih.gov, Mossoba, Miriam E.1, Steinberg, Seth M.2, Halverson, David C.1, Stroncek, David3, Khuu, Hahn M.3, Hakim, Frances T.1, Castiello, Luciano3, Sabatino, Marianna3, Leitman, Susan F.3, Mariotti, Jacopo1, Gea-Banacloche, Juan C.1, Sportes, Claude1, Hardy, Nancy M.1, Hickstein, Dennis D.1, Pavletic, Steven Z.1, Rowley, Scott4, Goy, Andre4, Donato, Michele4, Korngold, Robert4 |
|---|---|
| Zdroj: | Blood. 4/11/2013, Vol. 121 Issue 15, p2864-2874. 11p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|